BioMarin Pharmaceuticalvs.Moderna
BMRN vs MRNA · both in Biotech & innovation, part of the Medicine, pharma & life science value chain: Innovation-driven biotech companies focused on novel treatment modalities.
Moderna is about 2.4× larger than BioMarin Pharmaceutical by market cap; year to date, Moderna leads (+131.5% vs −0.5%).
Side by side
| BMRN | MRNA | |
|---|---|---|
| Market cap | $11.4B | $27.2B |
| Price | $59.12 | $68.27 |
| Today | −1.4% | −10.8% |
| Return YTD | −0.5% | +131.5% |
| Return 1Y | +0.5% | +99.2% |
| P/E | 42.6 | — |
| P/S | 3.5 | 12.2 |
| P/B | 1.8 | 3.7 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
BioMarin PharmaceuticalBMRN
Biopharma specialized in enzyme and gene therapies for rare genetic diseases.
Full BMRN profile →ModernaMRNA
American biotech company based on mRNA technology — known for the covid vaccine, with a pipeline in vaccines and oncology.
Full MRNA profile →More comparisons in Biotech & innovation
See where BMRN and MRNA sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →